Terns Pharmaceuticals Inc (NAS:TERN)
$ 7.12 0.13 (1.86%) Market Cap: 460.50 Mil Enterprise Value: 210.90 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 36/100

Terns Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 14, 2022 / 06:00PM GMT
Release Date Price: $6.25 (-1.57%)
George King
H.C. Wainwright & Co - Equity Research Associate

Good afternoon, everyone, and welcome to the last day of our 24th Annual Global Investment Conference. My name is George King, Equity Research Associate at H.C. Wainwright, and it's my pleasure to introduce our next speaker from Terns Pharmaceuticals. Please welcome, President and Head of R&D, Erin Quirk.

Erin Quirk
Terns Pharmaceuticals, Inc. - President, Head of R&D

George, thanks very much for the introduction, and thanks also to you and the entire H.C. Wainwright team for the opportunity to be here today and provide an overview of Terns. And good afternoon, everyone. I invite you all to go to our website to review our forward-looking statements.

I'll spend just a moment on what I think is one of Terns' great strengths and that is our people. We have a highly seasoned management team that collectively has [scores] of years of experience in management and financing of biotechs, as well as in development of high-impact drugs. We have a stellar Board, and we are backed by a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot